Cancer Treatment Centers of America: Clinical Trials
Learn More About This Topic: Chat with Us | Email Us
A Phase 3 Randomized Open Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the Treatment of ErbB-2 Positive Locally Advanced or Metastatic Breast Cancer
Summary
The investigational study drug Neratinib is believed to have an impact on the growth of cancer cells. This study is looking at how this drug works compared to previosly approved drugs.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
